Document is current
Any future updates will be listed below
-
Authors
Hui, Caressa
Qu, Vera
Wang, Jen-Yeu
von Eyben, Rie
Chang, Yu-Cheng
Chiang, Po-Lin
Liang, Chih-Hung
Lu, Jen-Tang
Li, Gordon
Hayden-Gephart, Melanie
Wakelee, Heather
Neal, Joel
Ramchandran, Kavitha
Das, Millie
Nagpal, Seema
Soltys, Scott
Myall, Nathaniel
Pollom, Erqi
- License Information
-
More Information
Article History
Received: 24 August 2022
Accepted: 21 September 2022
First Online: 13 October 2022
Declarations
:
: For authors Yu-Cheng Chang, Po-Lin Chiang, Chih-Hung Liang, Jen-Tang Lu, a US patent is granted for Vysioneer software, and these authors also have Vysioneer Inc. stocks. For author Scott Soltys: Zap Surgical, Inc.—Speaker Honoraria; Novocure, Inc.—Research Funding; Accuray, Inc.—Consultant. For author Millie Das: Consulting: Jazz Pharmaceutics, Beigene, Astra Zeneca, Sanofi/Genzyme, Eurofins, Janssen, Genentech (uncompensated). Research: Merck, Genentech, CellSight, Novartis, Abbvie, United Therapeutics, Varian, Verily, Celgene. For author Melanie Hayden-Gephart: U54CA261717. All other authors have no conflicts of interest.
: This study did not require ethics approval.
